UFP Technologies

UFP Technologies Announces Record 2023 Results

Retrieved on: 
Wednesday, February 21, 2024

Net sales for 2023 were $400.1 million, 13.1% higher than 2022 sales of $353.8 million.

Key Points: 
  • Net sales for 2023 were $400.1 million, 13.1% higher than 2022 sales of $353.8 million.
  • Sales for the fourth quarter 2023 were $101.5 million, 11.2% higher than 2022 fourth quarter sales of $91.2 million.
  • “I am very pleased with our fourth quarter and full year 2023 results,” said R. Jeffrey Bailly, Chairman & CEO.
  • Full year 2023 adjusted operating income increased 37.9% to $61.3 million, from $44.5 million in the same period of 2022.

Mitchell Rock Named President of UFP Technologies

Retrieved on: 
Tuesday, February 6, 2024

NEWBURYPORT, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the appointment of Mitchell Rock as President of the Company.

Key Points: 
  • NEWBURYPORT, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the appointment of Mitchell Rock as President of the Company.
  • Rock has been serving as President of the Company’s MedTech business.
  • R. Jeffrey Bailly will continue in his capacity as Chairman and Chief Executive Officer.
  • “He is hard-working, well-known, and well-respected throughout our industry and within UFP Technologies.

UFP Technologies to Present and Host 1X1 Investor Meetings at the CJS Securities 24th Annual “New Ideas for the New Year” Virtual Conference

Retrieved on: 
Tuesday, January 9, 2024

NEWBURYPORT, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming CJS Securities 24th Annual “New Ideas for the New Year” Conference to be held virtually on January 10, 2024.

Key Points: 
  • NEWBURYPORT, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming CJS Securities 24th Annual “New Ideas for the New Year” Conference to be held virtually on January 10, 2024.
  • UFP’s presentation is scheduled to begin at 11:45 AM ET on Wednesday, January 10, 2024.

UFP Technologies to Present and Host 1X1 Investor Meetings at the Piper Sandler 35th Annual Healthcare Conference

Retrieved on: 
Tuesday, November 21, 2023

NEWBURYPORT, Mass., Nov. 21, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming Piper Sandler 35th Annual Healthcare Conference to be held in New York City November 28-30, 2023.

Key Points: 
  • NEWBURYPORT, Mass., Nov. 21, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming Piper Sandler 35th Annual Healthcare Conference to be held in New York City November 28-30, 2023.
  • UFP’s presentation is scheduled to begin at 2:30 PM on Wednesday, November 29.

UFP Technologies Announces Strong Q3 2023 Results

Retrieved on: 
Wednesday, November 1, 2023

Adjusted net income increased 44.4% to $35.8 million for the nine-month period ended September 30, 2023 from $24.8 million in the same period of 2022.

Key Points: 
  • Adjusted net income increased 44.4% to $35.8 million for the nine-month period ended September 30, 2023 from $24.8 million in the same period of 2022.
  • Sales for the nine-month period ended September 30, 2023 were $298.6 million compared to sales of $262.6 million in the same period in 2022.
  • “I am pleased with our Q3 results and progress on our growth initiatives, particularly our expansion plans in our low-cost country facilities,” said R. Jeffrey Bailly, Chairman & CEO.
  • Adjusted EBITDA increased to $60.2 million for the nine-month period ended September 30, 2023 from $44.9 million in the same period of 2022.

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the Midwest IDEAS Investor Conference August 23

Retrieved on: 
Monday, August 21, 2023

NEWBURYPORT, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman & CEO R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate at the Midwest IDEAS Investor Conference on August 23, 2023.

Key Points: 
  • NEWBURYPORT, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman & CEO R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate at the Midwest IDEAS Investor Conference on August 23, 2023.
  • UFP Technologies’ presentation is scheduled to begin at 9:20 AM CT on August 23.
  • The presentation will be webcast and can be accessed through the conference site, www.IDEASconferences.com , and in the investor relations section of the company's website: www.UFPT.com/Investors .

UFP Technologies Announces Record Q2 Results

Retrieved on: 
Tuesday, August 1, 2023

Sales for the second quarter were $100.0 million compared to sales of $94.3 million in the second quarter of 2022.

Key Points: 
  • Sales for the second quarter were $100.0 million compared to sales of $94.3 million in the second quarter of 2022.
  • “I am very pleased with our second quarter results,” said R. Jeffrey Bailly, Chairman & CEO.
  • “After adjusting prior-year sales for the divestment of our Molded Fiber business in July 2022, organic sales in Q2 grew 13%.
  • Gross margins improved to 29.6% from 25.8% in Q2 of last year.

UFP Technologies, Inc. to Present Virtually and Host 1X1 Investor Meetings at Sidoti Virtual Investor Conference on June 14, 2023

Retrieved on: 
Monday, June 12, 2023

UFP is an important link in the medical device supply chain and a valued outsource partner to most of the top medical device manufacturers in the world.

Key Points: 
  • UFP is an important link in the medical device supply chain and a valued outsource partner to most of the top medical device manufacturers in the world.
  • The Company today announced that Chairman & Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will present and host one-on-one meetings with investors at the Sidoti Virtual Investor Conference taking place on June 14-15, 2023.
  • ET on June 14 and can be accessed live at https://sidoti.zoom.us/webinar/register/WN_fmQXXPkUSJ-5vqL6tna4pQ , or in the investor relations section of the Company's website: www.ufpt.com .
  • UFP Technologies, Inc. will also host virtual one-on-ones with investors on Wednesday, June 14, 2023.

UFP Technologies Announces Record Q1 2023 Results

Retrieved on: 
Tuesday, May 2, 2023

“I am extremely pleased with our Q1 results, as sales grew 37.2% and EPS nearly doubled,” said R. Jeffrey Bailly, Chairman & CEO.

Key Points: 
  • “I am extremely pleased with our Q1 results, as sales grew 37.2% and EPS nearly doubled,” said R. Jeffrey Bailly, Chairman & CEO.
  • It grew 59.5% in Q1, driven by 112% growth in robotic surgery.
  • Net income increased 100.5% to $9.7 million in the first quarter of 2023, from $4.9 million in the first quarter of 2022.
  • EBITDA for the first quarter of 2023 increased 64.8% to $15.5 million from $9.4 million in the first quarter of 2022.

UFP TECHNOLOGIES, INC. to Present Virtually and Host 1X1 Investor Meetings at Sidoti Virtual Investor Conference on March 22, 2023

Retrieved on: 
Tuesday, March 21, 2023

The presentation will begin at 8:30 A.M.

Key Points: 
  • The presentation will begin at 8:30 A.M.
  • ET on March 22 and can be accessed live at https://sidoti.zoom.us/webinar/register/WN_SoSVsvnGTrONb3tSEwTGNA , or in the investor relations section of the Company's website: www.ufpt.com .
  • UFP Technologies, Inc. will also host virtual one-on-ones with investors on Wednesday, March 22, 2023.
  • Registration is free and you don't need to be a Sidoti client.